NGNE
Neurogene Inc
25.50$
-3.9%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 666.7 | 769.8 | – | – | – | – | – | – | – | |
| 30.5 | 53.4 | 57.1 | 53.1 | 58.4 | 56.0 | 77.2 | 14.2 | 17.8 | 14.3 | 17.8 | 15.6 | 22.7 | 61.2 | 81.8 | 127.4 | 64.8 | 62.2 | 75.5 | 60.6 | 51.2 | 28.5 | 16.1 | 9.5 | 5.2 | 4.4 | 9.5 | – | 2.4 | 1.3 | 5.0 | 4.0 | 5.2 | 1.1 | 0.8 | 1.2 | 1.4 | 1.2 | 1.9 | 3.3 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 549.7 | 701.7 | – | – | – | – | – | – | – | |
| – | – | – | -0.6% | -0.7% | -0.8% | -0.8% | -2.4% | -2.4% | -3.0% | – | -1.5% | -2.2% | -0.3% | -0.2% | -0.2% | -0.2% | -0.2% | -0.3% | -0.4% | -0.6% | -1.2% | -2.4% | -4.3% | -8.7% | -10.4% | -5.7% | -2.0% | -25.4% | -25.7% | -8.4% | -12.8% | -11.7% | -21.0% | -29.0% | -23.6% | -21.5% | -24.4% | -18.3% | -12.3% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2,649.4% | -3,155.2% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -7,444.9% | -8,197.4% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -5,146.7% | -5,756.4% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -8,540.4% | -8,981.6% | – | – | – | – | – | – | – | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | -33.3% | -39.6% | -50.7% | -65.8% | -43.9% | -56.0% | -43.5% | -26.8% | -30.5% | -99.0% | -49.0% | -55.3% | -66.5% | -14.3% | -17.4% | -22.1% | -26.9% | -37.6% | -42.5% | -47.0% | -52.8% | -55.6% | -57.8% | -66.3% | – | -69.3% | -19.5% | -24.0% | -30.7% | -38.7% | -24.2% | -27.7% | -30.9% | -32.1% | -34.1% | -41.5% | -51.2% | |
| – | – | – | -31.1% | -37.1% | -45.5% | -59.1% | -38.1% | -48.9% | -40.7% | -25.4% | -30.0% | -94.9% | -47.2% | -49.6% | -58.9% | -13.0% | -15.8% | -19.8% | -24.0% | -33.1% | -37.2% | -41.0% | -45.0% | -46.4% | -52.2% | -54.8% | -67.7% | -58.2% | -16.3% | -21.0% | -26.5% | -32.4% | -22.4% | -25.6% | -28.4% | -29.6% | -31.2% | -37.5% | -45.5% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | -72 | -66 | -142 | -139 | -130 | -202 | -192 | -178 | -164 | -155 | -141 | -127 | -76 | -39 | -81 | -34 | -44 | -23 | -145 | -147 | -108 | -63 | -134 | -67 | -55 | -67 | -101 | -121 | -109 | |
| 94.7% | 93.7% | 95.5% | 93.5% | 93.8% | 89.6% | 89.8% | 86.8% | 87.4% | 93.6% | 94.8% | 98.1% | 95.8% | 96.4% | 89.6% | 88.6% | 90.4% | 90.8% | 89.4% | 89.3% | 88.0% | 87.5% | 87.2% | 85.2% | 83.5% | 90.3% | 82.6% | -247.5% | 84.0% | 83.6% | 87.4% | 86.2% | 83.7% | 92.4% | 92.5% | 91.9% | 92.3% | 91.6% | 90.4% | 88.9% | |
| – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | -1.77 | -1.92 | -2.14 | -2.41 | -1.67 | -1.83 | -1.34 | -0.81 | -0.94 | -2.53 | -1.97 | -1.54 | -1.73 | -0.53 | -0.79 | -0.72 | -0.82 | -1.06 | -1.43 | -1.11 | -1.12 | -1.38 | -1.34 | -0.97 | -0.39 | -4.70 | -2.83 | -2.42 | -2.81 | -3.14 | -5.06 | -3.85 | -4.01 | -4.02 | -5.83 | -4.42 | -4.93 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.05 | 0.05 | 0.00 | 0.00 | -0.04 | -0.04 | 0.00 | 0.00 | 0.00 | |
| 8.78 | 6.18 | 5.85 | 5.32 | 4.86 | 4.21 | 3.66 | 3.80 | 3.26 | 3.09 | 3.04 | 3.07 | 2.55 | 4.02 | 2.79 | 2.61 | 3.70 | 4.53 | 3.26 | 3.04 | 2.81 | 3.36 | 2.36 | 2.11 | 2.48 | 2.31 | 1.47 | -1.43 | 6.78 | 14.51 | 10.10 | 9.15 | 8.11 | 20.89 | 13.90 | 12.98 | 12.54 | 17.10 | 10.66 | 9.63 | |
| – | – | – | -1.62 | -1.86 | -1.97 | -2.15 | -1.29 | -1.38 | -1.32 | – | -0.72 | -1.25 | -0.66 | -0.41 | -0.57 | -0.42 | -0.65 | -0.65 | -0.74 | -0.88 | -1.19 | -0.92 | -0.85 | -1.11 | -1.07 | -0.80 | -0.33 | -4.06 | -4.98 | -4.26 | -4.66 | -4.90 | -4.81 | -3.39 | -3.54 | -3.71 | -5.02 | -3.70 | -3.86 | |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.